Graybug Vision Inc
GRAY
Get informed when a big investor buys or sells
+ FollowMarket Cap$120.98M
Close$
Share Statistics
| Market cap | $120.98 Million |
|---|---|
| Enterprise Value | $112.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.97 |
| Beta | 1.2 |
| Outstanding Shares | 15,011,321 |
Return
| Return on Equity | 1770.29% |
|---|---|
| Return on Assets | -227.02% |
| Return on Invested Capital | -674.97% |
Valuation & Multiples
| P/E Ratio | -4.22 |
|---|---|
| PEG | 2.13 |
| Price to Sales | - |
| Price to Book Ratio | -5.5 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.07 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Graybug Vision Inc
31 employeesGraybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company’s proprietary ocular delivery technologies are designed to main...